Effects of Long-term Remote Ischemic Preconditioning on Clinical Outcome in Patients With Acute Myocardial Infarction

Last updated: September 12, 2025
Sponsor: Henan Institute of Cardiovascular Epidemiology
Overall Status: Active - Recruiting

Phase

N/A

Condition

Angina

Treatment

RIPerC

RIPC

Clinical Study ID

NCT07181356
HenanICE202105
  • Ages > 18
  • All Genders

Study Summary

At present, there are 290 million cardiovascular patients in China, including 11 million patients with coronary heart disease. Remote ischemic preconditioning(RIPC) may play an effective endogenous cardiac protection.This study will explore whether long-term use of RIPC in patients with AMI after PCI and non interventional therapy can reduce the incidence of major adverse cardiovascular cerebrovascular events(MACCE) and improve clinical outcomes and long-term prognosis.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with acute myocardial infarction were diagnosed in accordance with thecriteria of the "Global Unified Definition of Fourth Myocardial Infarction"

Exclusion

Exclusion Criteria:

  • The patients could not tolerate RIPC or RIPerC

  • Aortic dissection, coronary artery aneurysm, coronary artery fistula and othersystemic organic diseases

  • The uncontrolled systolic blood pressure and diastolic blood pressure of severehypertension were 180 mmHg and 120 mmHg respectively

  • severe liver dysfunction (bilirubin > 20 mmol / L, prothrombin time > 2.0 ratio)

  • Severe renal insufficiency (GFR < 30 ml / min / 1.73 m2);

  • patients taking nicorandil and other drugs affecting microcirculation

  • pregnant

Study Design

Total Participants: 2146
Treatment Group(s): 2
Primary Treatment: RIPerC
Phase:
Study Start date:
January 01, 2025
Estimated Completion Date:
December 01, 2028

Study Description

A total of 2146 patients with AMI are expected included as the research objects and randomly divided into experimental group and control group with 1073 cases in each group. After admission, Patients in the experimental group received everyday RIPC of upper limbs to the end of follow-up.The control group is a blank control and undergoes conventional medical procedures. Routine blood indexes, ultrasound, electrocardiogram, were detected On the day of admission. 12 months post- discharge, the incidence of MACCE(include Cardiovascular death, non-fatal acute myocardial infarction, stent thrombosis, revascularization, stroke, admission due to heart failure and the above composite events were independent components) and Poce(All deaths, all strokes, all myocardial infarction, or all revascularization events)will recorded by telephone follow-up.

Connect with a study center

  • Fuwai Central China Cardiovascular Hospital

    Zhengzhou 1784658, Henan 1808520 450000
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.